Phase II - IV Clinical

Doug Kalman, Director of QPS MRA, publishes on a New Cream for the Treatment of Actinic Keratosis

Actinic keratosis lesions (AKs) have the potential to develop into squamous cell carcinoma (SCC) and thus therapies to prevent SCC development from AKs are warranted. The aim of this study was to assess the effects of a 3 month application of a canola phenolic acid-based cream (CPA) on AK lesions.

The results of this study and previous in vitro studies suggest a potential role for CPA in the treatment of AK lesions and the prevention of SCC development.

20 years in pharma R&D navigation